23 chronic insomnia patients treated with ZLT-101, Zelira’s proprietary and patented medicinal cannabis formulation, demonstrated statistically significant improvement in Insomnia Severity Index scores compared to placebo.
This research evaluates thousands of subjects who are current or past participants in the Pennsylvania Medical Marijuana Program who were asked to answer a variety of questions based on their first-hand experience.
As more of our patients are consuming cannabis on a regular basis, a common issue seems to be arising – TOLERENCE.
In light of recent news stories regarding vaping and safety, ILERA Healthcare would like to clearly state that our vaping products are 100% Vitamin E acetate FREE, and have always been free from any vitamin acetates or additives.
Pennsylvania’s premiere medical cannabis cultivation and dispensary company, IleraHealthcare, has tapped Dr. Oludare “Dare” Odumosu as Chief Scientific Officer/EVP Pharmaceutical Division.
The Pennsylvania Medical Marijuana Program began over 2 years ago when it was signed into law on April 17, 2016. Since then, over 750 physicians registered for the program.
Ilera was recently featured in the Chestnut Hill Local.